论文部分内容阅读
近年许多大型随机对照试验结果显示,他汀类药物即羟甲基戊二酰辅酶A还原酶抑制剂(3-hydroxy-3-methylglutaryco-enzyme A reductase inhibitors,HRI),除降血脂外尚有诸多非降脂作用,如减缓动脉粥样硬化进程和管腔狭窄、降低心血管意外危险、降低脑卒中危险、降低糖尿病危险、改
In recent years, many large randomized controlled trials showed that statins, namely hydroxy-3-methylglutarylco-enzyme A reductase inhibitors (HRI), in addition to lipid-lowering there are many non- Lipid-lowering effects, such as slowing the process of atherosclerosis and stenosis, reduce the risk of cardiovascular accidents, reduce the risk of stroke, reduce the risk of diabetes, change